2004
DOI: 10.1159/000079971
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Enhancer Activity of a Dinucleotide Repeat Polymorphism in the Neurotrophin-3 Gene and Its Association with Bipolar Disorder

Abstract: Growing evidence has implicated the possible involvement of neurotrophins in the pathogenesis of functional psychoses such as schizophrenia and bipolar disorder. Previous studies reported a significant association of a dinucleotide repeat polymorphism of the neurotrophin-3 (NTF3) gene with schizophrenia. The aims of the present study were to examine whether this polymorphism is associated with bipolar disorder and whether the polymorphic region has an enhancer/silencer effect on transcriptional activity in an … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…As negative control, an empty pGL3-Basic vector was simultaneously transfected in all the experiments. At 24 h after transfection, luciferase activity was measured using a Dual-Luciferase Reporter Assay System (Promega) and a Lumat LB 9507 luminometer (Berthold, Bad Wildbad, Germany), as described previously (Tadokoro et al, 2004;Okada et al, 2006). Firefly and Renilla luciferase activities were quantified sequentially as relative light unit (RLU) by addition of their respective substrates according to the protocol of the supplier.…”
Section: Promoter Assay In Primary Cultured Neuronsmentioning
confidence: 99%
“…As negative control, an empty pGL3-Basic vector was simultaneously transfected in all the experiments. At 24 h after transfection, luciferase activity was measured using a Dual-Luciferase Reporter Assay System (Promega) and a Lumat LB 9507 luminometer (Berthold, Bad Wildbad, Germany), as described previously (Tadokoro et al, 2004;Okada et al, 2006). Firefly and Renilla luciferase activities were quantified sequentially as relative light unit (RLU) by addition of their respective substrates according to the protocol of the supplier.…”
Section: Promoter Assay In Primary Cultured Neuronsmentioning
confidence: 99%
“…At 24 h after transfection, luciferase activity was measured by using Dual-Luciferase Reporter Assay System (Promega, Tokyo, Japan) and a Lumat LB9507 luminometer (Berthold Technologies, Bad Wildbad, Germany), as described previously. 24 Firefly and renilla luciferase activities were quantified sequentially as relative light units (RLU) by addition of their respective substrates. The ratio of firefly RLU to renilla RLU of each sample was automatically computed.…”
Section: Association Analysis With Bipolar Disordermentioning
confidence: 99%
“…BDNF and NT-3 have been proposed as susceptibility genes for major depressive disorder and schizophrenia (Lin and Tsai, 2004;Tadokoro et al, 2004;Schumacher et al, 2005) and for other neuropsychiatric disorders (Ribases et al, 2005;Liu et al, 2005). Administration of brainderived neurotrophic factor (BDNF-Mouse Genome Informatics) or neurotrophin-3 (NT3; NTF3-Mouse Genome Informatics) into the dentate gyrus or CA3 region of hippocampus causes antidepressantlike effects in the forced swim and learned helplessness tests (Shirayama et al, 2002) and activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects (Saarelainen et al, 2003).…”
mentioning
confidence: 99%